Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

147.46 +1.59 (+1.09%)
Official Closing Price Updated: 7:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9 Next >
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
From Agilent Technologies Inc.
Via Business Wire
Agilent Joins AMBIC to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Agilent to Participate at Cowen and Barclays Health Care Conferences
From Agilent Technologies Inc.
Via Business Wire
Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
From Agilent Technologies Inc.
Via Business Wire
Published Study Details Proof-of-Concept for COVID-19 Detection via Saliva Screening
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports First-Quarter Fiscal Year 2022 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Acquires Artificial Intelligence Technology to Enhance Lab Productivity
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 21 Cents per Share
From Agilent Technologies, Inc.
Via Business Wire
Agilent Highlights Integrated Automation Solutions at SLAS 2022
From Agilent Technologies Inc.
Via Business Wire
Agilent and A*STAR’s SIFBI Sign Research Collaboration Agreement to Advance Singapore Agri-Food Industry
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces the Innovative Seahorse XF Pro Analyzer
From Agilent Technologies Inc.
Via Business Wire
Agilent to Webcast First-Quarter Fiscal Year 2022 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Agilent Presents Thought Leader Award to Professor Jason Kovacic
From Agilent Technologies Inc.
Via Business Wire
Caprikrn LLC- Supply Chain Management in 2022 - Resilience as a last resort
Fluctuations in demand and supply, material shortages, logistics problems, cyber-attacks, and, of course, health risks have characterized the past two pandemic years. 
Via IssueWire
Topics Economy
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at Evercore ISI Virtual Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Dr. Otis Brawley Named to Agilent Board of Directors
From Agilent Technologies, Inc.
Via Business Wire
Agilent Increases Cash Dividend to 21 Cents Per Share
From Agilent Technologies, Inc.
Via Business Wire
Agilent Names John Palma to Lead Global Medical Affairs Organization
From Agilent Technologies, Inc.
Via Business Wire
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
From Agilent Technologies Inc.
Via Business Wire
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
From Agilent Technologies Inc.
Via Business Wire
Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
From Agilent Technologies, Inc.
Via Business Wire
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
From Agilent Technologies Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.